Topic List : Precision Health
Tracking cancer evolution in the blood
Monitoring cancer DNA in blood can predict recurrence and prognosis and drive treatment decisions. A Stanford study of 92 lymphoma patients suggests similar techniques may work for other tumors.
High-intensity statins decrease mortality rates
In a retrospective study of a large population of patients with cardiovascular disease, Stanford researchers concluded that high-intensity statin treatments increased rates of survival.
Paving the way for gene therapy
Using the CRISPR gene-editing technique in stem cells, Stanford researchers repaired the gene that causes sickle cell disease, and the mended stem cells were successfully transplanted into mice.
Gene therapy for blistering skin disease
A trial in which genetically altered skin was grafted onto patients’ chronic wounds marks the first time that skin-based gene therapy has been demonstrated to be safe and effective in humans.
Plans for the nation’s first hadron center for cancer therapy
Hadron therapy, which relies on beams of charged particles including protons and heavier ions such as carbon, is expected to increase cancer cure rates because it can be used to treat larger tumors or those resistant to conventional radiotherapy.
Surgery relieves symptoms of heart anomaly
A Stanford study shows that a type of surgery improves the quality of life for patients with myocardial bridging, a congenital condition caused by a major artery tunneling through heart muscle.
New blood test may predict cardiovascular disease
An assessment blending several measures of immune-cell responsiveness predicted cardiovascular problems in individuals who likely would have slipped under the radar.
Technique can predict if antidepressants will help
Researchers were able to predict with 80 percent accuracy whether antidepressants would help patients by analyzing their brain function and personal history.
When prions don’t cause mad cow disease
Researchers have found nearly 50 helpful prions in yeast and comparable proteins in humans, suggesting that this dreaded protein type can boost survival and plays a role in evolution.
A baby with a mosaic heart
Researchers have solved the mystery of an infant with severe long QT syndrome, found to be caused by a lethal genetic defect in only 8 percent of her cells.